Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 0.9640
-0.0560 (-5.49%)
Apr 15, 2026, 4:59 PM CET
Stenocare Revenue
In the year 2025, Stenocare had annual revenue of 1.22M DKK. Stenocare had revenue of -3.19M in the quarter ending December 31, 2025.
Revenue
1.22M
Revenue Growth
n/a
P/S Ratio
17.02
Revenue / Employee
305.75K
Employees
8
Market Cap
41.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.22M | 19.70M | - |
| Dec 31, 2024 | -18.47M | -22.23M | - |
| Dec 31, 2023 | 3.76M | -731.58K | -16.30% |
| Dec 31, 2022 | 4.49M | 2.60M | 137.54% |
| Dec 31, 2021 | 1.89M | 1.69M | 852.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 309.06B |
| Coloplast | 27.89B |
| Genmab | 23.66B |
| ALK-Abelló | 6.31B |
| Gubra | 2.64B |
| Scandinavian Medical Solutions | 245.44M |
| BioPorto | 40.29M |
| Monsenso | 8.91M |